KP Bioscience

R&D

We become the most trusted partner of our customers and make a better life for patients

Development process

“To discover, development and deliver to patients
New medicines for the treatment of eye disorders”

Pipeline Indication lead optimization preclinical clinical phase I
KP-VR2 wet AMD
diabetic retinopathy
solid cancer
KP-IB dry AMD
KP-FR late wet AMD
KP-TR neovascular glaucoma